IP Library Granted Patent US 9,149,451
Granted Patent B1
US 9,149,451 · App. 14/101,046 · Granted Oct 6, 2015

Apparatus and method of stimulating elevation of glutathione levels in a subject

Inventor: David G. Schmidt (Poway, CA)
Assignee: Lifewave, Inc.
A61K31/198
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,149,451
App. No.
14/101,046
Granted
Oct 6, 2015
Kind
B1
Abstract

An apparatus configured to provide a beneficial biological effect for a subject, and/or a method of treating the subject using the apparatus. The apparatus may be configured to trigger and maintain the elevation of Glutathione levels within the subject. The apparatus may rely on a non-invasive mechanism to elevate Glutathione levels in the subject. The apparatus may not require a traditional power source such as a battery or wall plug in order to be effective in elevating Glutathione levels in the subject. To trigger and maintain the elevation of Glutathione levels within the subject, the apparatus may transmit communication to the body of the subject that results in increased levels of Glutathione within the subject.

Claims (14)

1. A method of treating a subject, the method comprising:

elevating Glutathione levels by a therapeutically effective amount by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises:

(A) one or more substrates;

(B) a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject without directly contacting the subject, the proximity of the one or more substrates and the chemical mixture to the subject trigger and maintain an increase in Glutathione levels in the body of the subject; and

(C) an enclosure that surrounds the one or more substrates and the chemical mixture and is configured to prevent the one or more substrates and/or the chemical mixture from coming into direct contact with and entering the body of the subject.

2. The method of claim 1 , wherein the chemical mixture comprises Glutathione.

3. A method of treating a subject, the method comprising:

treating a subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, exposure to a chemical weapon, an effect of mercury exposure, or diabetes by elevating Glutathione levels in the subject to a therapeutically effective level by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises:

(D) one or more substrates;

(E) a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject without directly contacting the subject, the proximity of the one or more substrates and the chemical mixture to the subject trigger and maintain an increase in Glutathione levels in the body of the subject; and

(F) an enclosure that surrounds the one or more substrates and the chemical mixture and is configured to prevent the one or more substrates and/or the chemical mixture from coming into direct contact with and entering the body of the subject.

4. The method of claim 3 , wherein the chemical mixture comprises Glutathione.

5. The method of claim 3 , wherein treating the subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises treating the subject for side effects of another treatment administered to the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes.

6. The method of claim 3 , wherein treating the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises elevating the Glutathione levels within the body of the subject.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2018
From: LIFEWAVE, INC.
To: SOLETLUNA HOLDINGS, INC.
Reel/Frame 045799/0586 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 032208 FRAME 0888. ASSIGNOR(S) HEREBY CONFIRMS THE CERTIFICATE OF MERGER. Recorded Apr 11, 2014
From: LIFEWAVE PRODUCTS, LLC
To: LIFEWAVE CONSOLIDATION CORPORATION
Reel/Frame 032662/0770 →
CHANGE OF NAME Recorded Apr 11, 2014
From: LIFEWAVE CONSOLIDATION CORPORATION
To: LIFEWAVE, INC.
Reel/Frame 032671/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2014
From: SCHMIDT, DAVID
To: LIFEWAVE PRODUCTS LLC
Reel/Frame 032208/0848 →
MERGER Recorded Feb 12, 2014
From: LIFEWAVE PRODUCTS LLC
To: LIFEWAVE, INC.
Reel/Frame 032208/0888 →
Continuity (1)
Division 12121674 · May 15, 2008